For seronegative CIDP patients we developed a screening approach to identify IgG and IgM antibodies using the three main cellular components of the peripheral nerve: motor neurons, DRG neurons and Schwann cells. The gene discussed is CD40LG; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.